Lester B R, Peck E J
Brain Res. 1979 Jan 26;161(1):79-97. doi: 10.1016/0006-8993(79)90197-5.
Sodium-dependent (+Na) and sodium-independent (-Na) receptive sites for gamma-aminobutyric acid (GABA) have been characterized using synaptic plasma membranes from bovine and rat brain. Synaptic plasma membranes were prepared from either rat cerebellar cortex or calf cerebral cortex by discontinuous sucrose gradient flotation centrifugation of crude mitochondrial pellets, and assayed using equilibrium ligand binding assays to obtain the maximum binding capacity (Bmax) and the thermodynamic constant (KD). Values for KD from equilibrium studies were subsequently confirmed by kinetic analyses of association and dissociation reactions. The KD for +Na GABA binding (5.0 +/- 0.2 micron) corresponds to the apparent Michaelis constant for neuronal GABA transport (3.8 +/- 0.1 micron)22, while the KD for -Na binding (0.17 +/- 0.04 micron) agrees with that determined by Enna and Snyder for the putative postsynaptic receptor. Maximal binding activities of about 5 and 55 pmole/mg protein were obtained for -Na and +Na binding respectively. The pharmacologic specificities of the two sites were determined using competition binding studies. Nipecotic acid and diaminobutyric acid inhibit both synaptosomal GABA uptake (Ki approximately 25 micron and 120 micron respectively) and +Na binding of GABA to synaptic plasma membrane (IC50 approximately 40 micron and 350 micron respectively) but do not inhibit -Na binding. Bicuculline inhibits -Na [3H]GABA binding at low concentrations (IC50 approximately 15 micron), while affecting the uptake and +Na binding of [3H]GABA only at high concentrations (IC50 approximately 520 micron and 300 micron respectively). beta-Alanine inhibits the -Na binding site (IC50 approximately 100 micron), but is ineffective at the +Na binding site and does not interfere with synaptosomal uptake of GABA. Finally, chlorpromazine and N-ethylmaleimide inhibit the +Na binding, albeit at high concentrations (IC50 approximately 600 micron and 5 mM respectively) but are ineffective at the -Na binding site. From these results the -Na binding site is tentatively identified as a postsynaptic receptor and the +Na binding site is identified as the neuronal uptake receptive site.
利用牛脑和大鼠脑的突触质膜,对γ-氨基丁酸(GABA)的钠依赖性(+Na)和钠非依赖性(-Na)受体位点进行了表征。通过对粗线粒体沉淀进行不连续蔗糖梯度浮选离心,从大鼠小脑皮质或小牛大脑皮质制备突触质膜,并使用平衡配体结合测定法进行测定,以获得最大结合容量(Bmax)和热力学常数(KD)。随后通过对结合和解离反应的动力学分析,证实了平衡研究中KD的值。+Na GABA结合的KD(5.0±0.2微摩尔)对应于神经元GABA转运的表观米氏常数(3.8±0.1微摩尔)22,而-Na结合的KD(0.17±0.04微摩尔)与Enna和Snyder对假定的突触后受体所测定的值一致。-Na和+Na结合的最大结合活性分别约为5和55皮摩尔/毫克蛋白质。使用竞争结合研究确定了两个位点的药理学特异性。尼克酸和二氨基丁酸既抑制突触体GABA摄取(Ki分别约为25微摩尔和120微摩尔),也抑制GABA与突触质膜的+Na结合(IC50分别约为40微摩尔和350微摩尔),但不抑制-Na结合。荷包牡丹碱在低浓度时抑制-Na [3H]GABA结合(IC50约为15微摩尔),而仅在高浓度时影响[3H]GABA的摄取和+Na结合(IC50分别约为520微摩尔和300微摩尔)。β-丙氨酸抑制-Na结合位点(IC50约为100微摩尔),但在+Na结合位点无效,且不干扰突触体对GABA的摄取。最后,氯丙嗪和N-乙基马来酰亚胺抑制+Na结合,尽管是在高浓度时(IC50分别约为600微摩尔和5毫摩尔),但在-Na结合位点无效。根据这些结果,-Na结合位点初步被确定为突触后受体,而+Na结合位点被确定为神经元摄取受体位点。